- IMMUPHARMA AT BIO-EQUITY 2024 12-14 May
- Grant of Share Options
- New intellectual property strategy initiated
- Incanthera provides Comm'l Update/Revenue F'casts
- Grant of Share Options
- IMMUPHARMA AT BIO-EUROPE SPRING 2024
- Financial, Business and Portfolio Develop't Update
- Holding(s) in Company
- Simbec-Orion appointed as CRO
- Incanthera - Comm'l Skincare Deal/£1M Fundraise
More ▼
Key statistics
On Friday, ImmuPharma PLC (IMM:LSE) closed at 2.14, 160.34% above the 52 week low of 0.822 set on Mar 04, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.19 |
---|---|
High | 2.20 |
Low | 2.19 |
Bid | 2.00 |
Offer | 2.30 |
Previous close | 2.14 |
Average volume | 1.02m |
---|---|
Shares outstanding | 416.44m |
Free float | 237.37m |
P/E (TTM) | -- |
Market cap | 8.91m GBP |
EPS (TTM) | -0.0092 GBP |
Data delayed at least 20 minutes, as of Apr 26 2024 15:55 BST.
More ▼